Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-008215
Filing Date
2017-08-03
Accepted
2017-08-03 18:01:08
Documents
1
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3080117eisenberg_oramed.html 3  
1 OWNERSHIP DOCUMENT f3080117eisenberg_oramed.xml 3 4579
  Complete submission text file 0001213900-17-008215.txt   6225
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address HI-TECH PARK 2/4 GIVAT- RAM PO BOX 39098 JERUSALEM L3 91390
Business Address
Eisenberg Hilla (Reporting) CIK: 0001712524 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35813 | Film No.: 171006326